Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale

• Published in: Journal of the American Geriatrics Society (JAGS) Vol. 71; no. 6; pp. 1701 - 1713
• Main Authors: Pajewski, Nicholas M., Dolor, Rowena J., Peeples, Sheronda R., Henrie, Adam M., Mixon, Amanda S., VanWormer, Jeffrey J., Kistler, Christine E., Knowlton, Kirk U., Newby, L. Kristin, Cicek, Mine S., Williams, Neely A., Ou, Jiafu, Shah, Raj C., Romashkan, Sergei, Weiner, Mark, Snyder, Heather, Carrillo, Maria, Rothman, Russell, Nauman, Beth, McTique, Kathleen, Owens, Alva, Heimberg, Murray, Massey, Jesse, Lovato, Jeanette, White, Jack, Gaziano, Michael, Poddar, Krishna, Taylor, Zachary, Hervey, Jennifer, Kelsey, Michelle, Batch, Bryan, Richmond, Al, Chang, Alain, Pahor, Marco, Rapp, Steve, Sachs, Bonnie, Kapitanovsky, Karina, Cicek, Mina, Dohner, Claire, VanDoren, Kyra, Breitner, John, Travison, Tom, Burnet, Katie, Vanterpool, Yessica Estrella, Oberembt, Sandra, Shade, Lindsay, Strout, Kelsey, Rao, Sohail, Cardoso, Esmeralda, Allen, Jenifer, Cripps, Shanelle, Ford, Daniel, Kohnhorst, Diane, Druckrey, Joshua, Berendt, Madeline, Bazzano, Lydia, Williams, Shannon, Brill, Seuli, Jindra, Matthew, Yurko, Erin, Tapan, Mehta, Azhar, Gohar, Lu, Jane, Wells, Brandi, Gordon, Howard, Hart, Jennifer, Carrasquillo, Olveen, Hahn‐Cover, Kristin, Musi, Nicolas, Brown, Kevin, Wharton, Jennifer, Wall, Michele, Betancourt, Jesus, Almonte, Aimee, Munoz, Andres, Clarke, Jodie‐Ann, Hallock, Alexander, Spreyer, Kasey, Lee, Pearl, Chau, Kieu, Romero, Iliana, Tavabi, Amir, Penny, William, Eleazer, Paul, Thongsa, Stephen, Ricks, Jordan, Walsh, James, Michael, Jessica, Lockhart, Mechelle, Withee, Cortny, Todela, Teresa, Sullivan, Dennis, Gupta, Ankur, Castle, Tiffany, Kramer, Holly, Atlas, Steven, Kiran, Shamsa, Beaverson, Brandon, Venetucci, Julianna, Shivaswamy, Vijay
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.06.2023; Wiley Subscription Services, Inc
• Subjects: Angina; Atorvastatin; Cardiovascular diseases; Cerebral infarction; Clinical trials; cognition; Cognitive ability; Congestive heart failure; Dementia; Dementia - drug therapy; Dementia - prevention & control; Dementia disorders; Elder care; Electronic medical records; healthy aging; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Lipids; Myocardial infarction; Myocardial Infarction - drug therapy; older adults; Older people; Phenotypes; Placebos; Statins; Stroke - epidemiology; Survival; older adults; dementia; cognition; healthy aging; statins
• ISSN: 0002-8614; 1532-5415
• DOI: 10.1111/jgs.18312

Whether initiation of statins could increase survival free of dementia and disability in adults aged ≥75 years is unknown. PREVENTABLE, a double‐blind, placebo‐controlled randomized pragmatic clinical trial, will compare high‐intensity statin therapy (atorvastatin 40 mg) with placebo in 20,000 community‐dwelling adults aged ≥75 years without cardiovascular disease, disability, or dementia at baseline. Exclusion criteria include statin use in the prior year or for >5 years and inability to take a statin. Potential participants are identified using computable phenotypes derived from the electronic health record and local referrals from the community. Participants will undergo baseline cognitive testing, with physical testing and a blinded lipid panel if feasible. Cognitive testing and disability screening will be conducted annually. Multiple data sources will be queried for cardiovascular events, dementia, and disability; survival is site‐reported and supplemented by a National Death Index search. The primary outcome is survival free of new dementia or persisting disability. Co‐secondary outcomes are a composite of cardiovascular death, hospitalization for unstable angina or myocardial infarction, heart failure, stroke, or coronary revascularization; and a composite of mild cognitive impairment or dementia. Ancillary studies will offer mechanistic insights into the effects of statins on key outcomes. Biorepository samples are obtained and stored for future study. These results will inform the benefit of statins for increasing survival free of dementia and disability among older adults. This is a pioneering pragmatic study testing important questions with low participant burden to align with the needs of the growing population of older adults.